Zhao Hailong, Cui Guonan, Jin Jing, Chen Xiaoguang, Xu Bailing
Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Bioorg Med Chem. 2016 Nov 15;24(22):5911-5920. doi: 10.1016/j.bmc.2016.09.049. Epub 2016 Sep 21.
Pin1 (Protein interacting with NIMA1) is a peptidyl prolyl cis-trans isomerase (PPIase) which specifically catalyze the conformational conversion of the amide bond of pSer/Thr-Pro motifs in its substrate proteins and is a novel promising anticancer target. A series of new thiazole derivatives were designed and synthesized, and their inhibitory activities were measured against human Pin1 using a protease-coupled enzyme assay. Of all the tested compounds, a number of thiazole derivatives bearing an oxalic acid group at 4-position were found to be potent Pin1 inhibitors with IC values at low micromolar level. The detailed structure-activity relationships were analyzed and the binding features of compound 10b (IC 5.38μM) was predicted using CDOCKER program. The results of this research would provide informative guidance for further optimizing thiazole derivatives as potent Pin1 inhibitors.
Pin1(与NIMA1相互作用的蛋白质)是一种肽基脯氨酰顺反异构酶(PPIase),它特异性催化底物蛋白中pSer/Thr-Pro模体酰胺键的构象转换,是一个新的有前景的抗癌靶点。设计并合成了一系列新的噻唑衍生物,采用蛋白酶偶联酶法测定了它们对人Pin1的抑制活性。在所有测试化合物中,发现许多在4位带有草酸基团的噻唑衍生物是有效的Pin1抑制剂,其IC值处于低微摩尔水平。分析了详细的构效关系,并使用CDOCKER程序预测了化合物10b(IC 5.38μM)的结合特征。本研究结果将为进一步优化噻唑衍生物作为有效的Pin1抑制剂提供信息指导。